Webinar recording - Accelerating Pain Therapeutic Discovery: Nav1.9 as a Drug Target for Treatment of Pain

Nav19 webinar header

In this on-demand webinar, experts discuss the crucial role of voltage-gated sodium channels, particularly Na_V1.9, in pain mechanisms, and how innovative technologies are unlocking new opportunities for non-opioid pain therapies.

Complete the form below to watch the presentations.

The Voltage-Gated Sodium Channel Na_V1.9 a Selective Target for Analgesic Drug Discovery (Associate Professor David Bulmer PhD, Group Leader University Associate Professor, University of Cambridge)
Development of a High-throughput Automated Electrophysiology Assay for Na_V1.9 (Dr Eddy Stevens, CSO, Metrion).

Recommended Publications

Latest Publications

Development of a High-Throughput Automated Electrophysiology Assay for Human Nav1.9 Inhibitor Screening

Alex Haworth, Senior Scientist at Metrion, introduces a poster demonstrating Metrion's development of a monoclonal CHO cell line expressing hNav1.9, validated via manual and automated patch clamp techniques.

Introduction to ion channel screening at Metrion

View All

Publication in support of refining the hERG testing strategy for silencing RNA (siRNA) receives ‘2024 Technology Innovation Publication Award’ from the Safety Pharmacology Society

Review of Academic Ion Channels Drug Discovery Workshop 2025

View All